Skip to content

Does the anaesthetic drug propofol affect the blood levels of the endogenous cannabis-like substance anandamide?

Effect of propofol on the peri-operative plasma level of the endogenous cannabinoid anandamide in patients undergoing minor elective surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000361909
Enrollment
30
Registered
2011-04-07
Start date
2011-03-10
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Anandamide is a body-own (endogenous) cannabis-like substance that is significantly involved in our response to stress, but also affects mood and has anti-nausea effects. In the proposed project we will investigate the effect of the drugs propofol and sevoflurane (two of the most commonly used anaesthetic agents) on the blood concentration of the cannabis-like substance anandamide in 30 patients having an operation at Royal Perth Hospital. In this trial, patients (15 each) will either receive an anaesthetic with propofol or with sevoflurane and we will measure the blood levels of anandamide by drawing blood (2x5ml) from a venous cannula anyway used to give the anaesthetic at 5 time points. Results of this project will help us to understand significant positive side effects of propofol, such as its anti-nausea properties.

Interventions

Maintenance of anaesthesia with intravenous propofol (target controlled infusion as clinically required: 4-6 mcg/ml)/fentanyl (as clinically required)

Sponsors

Thomas Ledowski
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

patients scheduled for minor non-emergency surgery

Exclusion criteria

Age < 18 yrs and > 65 yrs, ASA physical status > 2 (= significant comorbidity), history of chronic pain, a contraindication for any of the used drugs, and the incapacity to consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026